Auteur/autrice : oxeltis

Position:  Research Scientist (PhD), Montpellier -France, fix term contract 12-months, starting date October 4, 2021. Job Description The Research Scientist in medicinal chemistry will be responsible for the proposal, synthesis, (...)

Oxeltis is happy to participate and sponsor IS3NA-IRT 2021 Virtual meeting. Looking forward contacting you about your nucleos(t)ides medchem and custom synthesis programs.   https://www.is3na.org/events-1/2021-virtual-symposium

Oxeltis est heureux de participer et de sponsoriser le GECO 2021. Retrouvez-nous pour tous besoins de ressources externes sur vos programmes de chimie médicinale et de synthèse à façon. https://geco61.sciencesconf.org/

Oxeltis' scientists are participating to RICT 2021, lets connect and interact ! Why not planning a virtual meeting at contact@oxeltis.com https://www.rict2021.org/

https://resiconference.com Connect with Oxeltis at Resi Conference, 8-10 June 2021  #medicinalchemistry #smallmolecules #antivirals #medchemservices #networkinghttps://resiconference.com

Fonctions :     2 Attaché(e)s de Recherche, Montpellier - France, CDD 18 mois, à partir du 1er février 2021. Description du poste L’attaché(e) de recherche aura pour mission la synthèse, la (...)

Position:  Research Scientist (PhD), Montpellier -France, fix term contract 18-months, starting date Feb 1, 2021. Job Description The Research Scientist in medicinal chemistry will be responsible for the proposal, synthesis, (...)

Dr Stéphane Salamone and Dr Olivier Lavergne will be instrumental in boosting additional lab and medchem capabilities at the company Montpellier, France, November 9, 2020 – Oxeltis, a medicinal chemistry (...)

At Oxeltis, we are committed to continuing our medicinal chemistry research services during the Sars-Cov 2 outbreak, with respect to our staff’s safety and in accordance with the rules put in (...)

For the second year, Oxeltis is participating to the Medicinal Chemistry Symposium organized by the Pharmaceutical Society of Japan. Please visit us at Oxeltis booth #9 to talk about your (...)